SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk
Cases of necrotising fasciitis of the genitalia or perineum, also known as Fournier's gangrene, have been reported in patients with type 2 diabetes taking sodium glucose co-transporter 2 (SGLT2) inhibitors, the MHRA has said.
by Yejin Yang
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.